Skye Bioscience, Inc. Increase (Decrease) in Other Current Assets
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Other Current Assets of -$372.45 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14
- Skye Bioscience, Inc. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $244.78K.
- Skye Bioscience, Inc. increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$617.23K, a 160.58% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$48.14K.
- Skye Bioscience, Inc. increase (decrease) in other current assets for the quarter ending 2025-09-30 was $166.75K.
- Skye Bioscience, Inc. increase (decrease) in other current assets for fiscal 2025 was -$1.36M, a 195.92% decline from fiscal 2024.
- Skye Bioscience, Inc. increase (decrease) in other current assets for fiscal 2024 was $1.42M, a 189.54% increase from fiscal 2023.
- Skye Bioscience, Inc. increase (decrease) in other current assets for fiscal 2023 was $488.79K.
- Skye Bioscience, Inc. increase (decrease) in other current assets for fiscal 2022 was -$112.91K, a 299.50% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 6 month as first filed | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $244.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$372.45K 10-Q · filed 2026-08-14 | -$420.59K derived: sum of 3 quarters · filed 2026-08-14 | -$253.84K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$617.23K 10-Q · filed 2026-05-11 | -$665.37K derived: sum of 2 quarters · filed 2026-05-11 | -$498.62K derived: sum of 3 quarters · filed 2026-05-11 | -$2.99M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$48.14K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $118.61K derived: sum of 2 quarters · filed 2026-03-10 | -$2.38M derived: sum of 3 quarters · filed 2026-08-14 | -$1.36M 10-K · filed 2026-03-10 | ||
| 2025-09-30 | $166.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.33M derived: sum of 2 quarters · filed 2026-08-14 | -$1.31M 10-Q · filed 2025-11-10 | -$1.50M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.48M 10-Q · filed 2026-08-14 | -$1.67M derived: sum of 3 quarters · filed 2026-08-14 | -$1.89M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $1.02M 10-Q · filed 2026-05-11 | $827.64K derived: sum of 2 quarters · filed 2026-05-11 | $600.69K derived: sum of 3 quarters · filed 2026-05-11 | $2.05M derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | -$191.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$418.21K derived: sum of 2 quarters · filed 2026-03-10 | $1.03M derived: sum of 3 quarters · filed 2026-03-10 | $1.42M 10-K · filed 2026-03-10 | ||
| 2024-09-30 | -$226.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.22M derived: sum of 2 quarters · filed 2025-11-10 | $1.61M 10-Q · filed 2025-11-10 | $1.86M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.83M 10-Q · filed 2025-08-07 | $2.09M derived: sum of 3 quarters · filed 2025-08-07 | $1.89M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $386.51K 10-Q · filed 2025-05-08 | $638.52K derived: sum of 2 quarters · filed 2025-05-08 | $442.33K derived: sum of 3 quarters · filed 2025-05-08 | $616.86K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $252.01K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $55.81K derived: sum of 2 quarters · filed 2025-03-20 | $230.35K derived: sum of 3 quarters · filed 2025-03-20 | $488.79K 10-K · filed 2025-03-20 | $257.79K 10-K · filed 2024-03-22 | |
| 2023-09-30 | -$196.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$21.66K derived: sum of 2 quarters · filed 2024-11-07 | $236.78K 10-Q · filed 2024-11-07 | $36.88K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $174.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $432.98K 10-Q · filed 2024-08-09 | $233.08K derived: sum of 3 quarters · filed 2024-08-09 | $263.75K derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $258.44K 10-Q · filed 2024-05-10 | $58.55K derived: sum of 2 quarters · filed 2024-05-10 | $89.22K derived: sum of 3 quarters · filed 2024-05-10 | $92.66K derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | -$199.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$169.22K derived: sum of 2 quarters · filed 2024-03-22 | -$165.79K derived: sum of 3 quarters · filed 2024-03-22 | -$112.91K 10-K · filed 2024-03-22 | ||
| 2022-09-30 | $30.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $34.11K derived: sum of 2 quarters · filed 2023-11-14 | $86.99K 10-Q · filed 2023-11-14 | $143.58K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $3.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $56.32K 10-Q · filed 2023-08-07 | $56.32K 10-Q · filed 2022-08-15 | $112.91K derived: sum of 3 quarters · filed 2023-08-07 | $112.91K derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $52.88K 10-Q · filed 2023-05-12 | $109.47K derived: sum of 2 quarters · filed 2023-05-12 | $109.47K derived: sum of 3 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $56.59K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $56.59K derived: sum of 2 quarters · filed 2023-03-31 | $56.59K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | |||||
| 2020-12-31 | -$3.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$4.37K derived: sum of 2 quarters · filed 2022-03-28 | -$3.61K derived: sum of 3 quarters · filed 2022-03-28 | -$7.28K 10-K · filed 2022-03-28 | ||
| 2020-09-30 | -$1.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$555.00 derived: sum of 2 quarters · filed 2020-11-06 | -$4.22K 10-Q · filed 2020-11-06 | -$42.00 derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2020-06-30 | $755.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$2.91K 10-Q · filed 2020-08-13 | $1.27K derived: sum of 3 quarters · filed 2021-03-02 | |||
| 2020-03-31 | -$3.66K 10-Q · filed 2020-05-08 | $513.00 derived: sum of 2 quarters · filed 2021-03-02 | ||||
| 2019-12-31 | $4.17K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $4.94K 10-K · filed 2021-03-02 | ||||
| 2019-09-30 | $766.00 10-Q · filed 2020-11-06 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $0.00 derived: sum of 2 quarters · filed 2020-03-23 | $2.61K 10-K · filed 2020-03-23 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $2.61K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $2.61K 10-Q · filed 2019-08-09 | |||||
| 2017-12-31 | -$6.18K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$6.18K derived: sum of 2 quarters · filed 2019-03-14 | -$7.01K 10-K · filed 2019-03-14 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$831.00 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | -$831.00 10-Q · filed 2018-08-10 | |||||
| 2016-12-31 | -$21.61K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$21.61K derived: sum of 2 quarters · filed 2018-03-19 | -$21.61K derived: sum of 3 quarters · filed 2018-03-19 | -$29.11K 10-K · filed 2018-03-19 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | -$7.50K 10-Q · filed 2017-11-14 | -$2.48K derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$7.50K 10-Q · filed 2017-08-11 | -$2.48K derived: sum of 3 quarters · filed 2017-08-11 | -$3.48K derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | -$7.50K 10-Q · filed 2017-05-12 | -$2.48K derived: sum of 2 quarters · filed 2017-05-12 | -$3.48K derived: sum of 3 quarters · filed 2017-05-12 | -$3.48K derived: sum of 4 quarters · filed 2017-05-12 | ||
| 2015-12-31 | $5.02K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $4.02K derived: sum of 2 quarters · filed 2017-03-10 | $4.02K derived: sum of 3 quarters · filed 2017-03-10 | -$454.00 10-K · filed 2017-03-10 | ||
| 2015-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$1.00K derived: sum of 2 quarters · filed 2016-11-09 | -$5.47K 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$4.47K 10-Q · filed 2016-08-12 | ||||
| 2015-03-31 | -$4.47K 10-Q · filed 2016-05-13 | |||||
| 2014-12-31 | $36.58K 10-K · filed 2016-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |